321330-31-8 Usage
Explanation
Different sources of media describe the Explanation of 321330-31-8 differently. You can refer to the following data:
1. The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 16 carbon (C) atoms, 17 hydrogen (H) atoms, and 1 nitrogen (N) atom.
2. The compound is derived from naphthalene, a type of aromatic hydrocarbon with two fused benzene rings. It has a cyano group (C≡N) and an amino group (NH2) attached to the tetrahydronaphthalene ring, which is a partially hydrogenated form of naphthalene.
3. 1-AMINO-6-CYANO-1,2,3,4-TETRAHYDRONAPHTHYLENE is used in the synthesis of various pharmaceuticals and other organic compounds due to its unique chemical structure.
4. The compound's unique chemical structure and properties make it a promising candidate for use in the development of new drugs and pharmaceuticals.
5. As with any chemical compound, it is essential to handle 1-AMINO-6-CYANO-1,2,3,4-TETRAHYDRONAPHTHYLENE with care and follow appropriate safety protocols to minimize risks and ensure a safe working environment.
Chemical Structure
Naphthalene derivative with a cyano group and an amino group attached to the tetrahydronaphthalene ring
Application
Organic chemistry synthesis
Potential Applications
Medicinal chemistry and drug development
Safety Precautions
Handle with care and follow safety protocols in a laboratory setting
Check Digit Verification of cas no
The CAS Registry Mumber 321330-31-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,3,3 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 321330-31:
(8*3)+(7*2)+(6*1)+(5*3)+(4*3)+(3*0)+(2*3)+(1*1)=78
78 % 10 = 8
So 321330-31-8 is a valid CAS Registry Number.
321330-31-8Relevant articles and documents
INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS
-
Page/Page column 155-156, (2021/09/11)
The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
Piperazine derivatives and methods of use
-
Page/Page column 46, (2008/06/13)
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
CYCLIC AMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF INFLAMMATION-RELATED DISORDERS MEDIATED BY BRADYKININ
-
Page 114, (2010/02/09)
Compounds of formula (I) are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation mediated by Bradykinin. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes wherein q, t, R, Ra, Rb, Rc and R2 are as defined herein.
